Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

BACKGROUND: We evaluated the cost-effectiveness of posaconazole compared with standard azole therapy (SAT; fluconazole or itraconazole) for the prevention of invasive fungal infections (IFI) and the reduction of overall mortality in high-risk neutropenic patients with acute myelogenous leukaemia (AM...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau, Santiago, de la Cámara, Rafael, Sabater, Francisco J, Jarque, Isidro, Carreras, Enric, Casado, Miguel A, Sanz, Miguel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355034/
https://www.ncbi.nlm.nih.gov/pubmed/22471553
http://dx.doi.org/10.1186/1471-2334-12-83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355034/
https://www.ncbi.nlm.nih.gov/pubmed/22471553
http://dx.doi.org/10.1186/1471-2334-12-83

Ejemplares similares